BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23243173)

  • 1. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
    Bradshaw CS; Vodstrcil LA; Hocking JS; Law M; Pirotta M; Garland SM; De Guingand D; Morton AN; Fairley CK
    Clin Infect Dis; 2013 Mar; 56(6):777-86. PubMed ID: 23243173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
    Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
    J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early sexual experiences and risk factors for bacterial vaginosis.
    Fethers KA; Fairley CK; Morton A; Hocking JS; Hopkins C; Kennedy LJ; Fehler G; Bradshaw CS
    J Infect Dis; 2009 Dec; 200(11):1662-70. PubMed ID: 19863439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows.
    Marrazzo JM
    Clin Infect Dis; 2013 Mar; 56(6):787-9. PubMed ID: 23243177
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.
    Sanchez S; Garcia PJ; Thomas KK; Catlin M; Holmes KK
    Am J Obstet Gynecol; 2004 Dec; 191(6):1898-906. PubMed ID: 15592270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV.
    Vodstrcil LA; Walker SM; Hocking JS; Law M; Forcey DS; Fehler G; Bilardi JE; Chen MY; Fethers KA; Fairley CK; Bradshaw CS
    Clin Infect Dis; 2015 Apr; 60(7):1042-53. PubMed ID: 25516188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.
    Schwebke JR; Desmond RA
    Clin Infect Dis; 2007 Jan; 44(2):213-9. PubMed ID: 17173219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial.
    Vodstrcil LA; Plummer ME; Fairley CK; Tachedjian G; Law MG; Hocking JS; Worthington MK; Grant MM; Okoko N; Bradshaw CS
    Sci Rep; 2019 Mar; 9(1):3555. PubMed ID: 30837554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy.
    Hanson JM; McGregor JA; Hillier SL; Eschenbach DA; Kreutner AK; Galask RP; Martens M
    J Reprod Med; 2000 Nov; 45(11):889-96. PubMed ID: 11127100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M; Trouton KM
    Trials; 2015 Jul; 16():315. PubMed ID: 26210791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes.
    Darwish A; Elnshar EM; Hamadeh SM; Makarem MH
    J Obstet Gynaecol Res; 2007 Dec; 33(6):781-7. PubMed ID: 18001442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study.
    Bradshaw CS; Walker SM; Vodstrcil LA; Bilardi JE; Law M; Hocking JS; Fethers KA; Fehler G; Petersen S; Tabrizi SN; Chen MY; Garland SM; Fairley CK
    J Infect Dis; 2014 May; 209(10):1562-72. PubMed ID: 24285846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.